Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6635 | 1461 | 42.5 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
707 | 2 | MATRIX METALLOPROTEINASE//METALLOPROTEINASES//MT1 MMP | 12920 |
6635 | 1 | TACE INHIBITORS//MMP INHIBITORS//MATRIX METALLOPROTEINASE INHIBITOR | 1461 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TACE INHIBITORS | authKW | 752899 | 3% | 97% | 37 |
2 | MMP INHIBITORS | authKW | 329951 | 3% | 34% | 46 |
3 | MATRIX METALLOPROTEINASE INHIBITOR | authKW | 268257 | 3% | 26% | 49 |
4 | GELATINASE INHIBITOR | authKW | 194515 | 1% | 85% | 11 |
5 | ZINC BINDING GROUP | authKW | 147290 | 1% | 41% | 17 |
6 | MMP 2 INHIBITORS | authKW | 146290 | 0% | 100% | 7 |
7 | HYDROXAMATE | authKW | 128235 | 3% | 17% | 37 |
8 | MATRIX METALLOPROTEINASE | authKW | 107131 | 13% | 3% | 193 |
9 | ABT BIOCHEM 1 | address | 99567 | 1% | 53% | 9 |
10 | 47J | address | 87076 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 23528 | 38% | 0% | 549 |
2 | Chemistry, Organic | 3288 | 22% | 0% | 327 |
3 | Biochemistry & Molecular Biology | 2998 | 39% | 0% | 572 |
4 | Pharmacology & Pharmacy | 398 | 12% | 0% | 176 |
5 | Biophysics | 305 | 6% | 0% | 92 |
6 | Biochemical Research Methods | 298 | 6% | 0% | 83 |
7 | Chemistry, Multidisciplinary | 102 | 9% | 0% | 125 |
8 | Cell Biology | 69 | 6% | 0% | 83 |
9 | Rheumatology | 43 | 1% | 0% | 19 |
10 | Chemistry, Analytical | 24 | 3% | 0% | 49 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT BIOCHEM 1 | 99567 | 1% | 53% | 9 |
2 | 47J | 87076 | 0% | 83% | 5 |
3 | CANC AREA | 75230 | 0% | 60% | 6 |
4 | HOKKAIDO ABORAT | 47020 | 0% | 75% | 3 |
5 | INFLAMMAT ONCOL | 47020 | 0% | 75% | 3 |
6 | CHEM PHYS SCI INFLAMMATORY DIS | 41797 | 0% | 100% | 2 |
7 | MEDBIOMOL IFR53 | 41797 | 0% | 100% | 2 |
8 | PHARMBIOMOL IFR53 | 41797 | 0% | 100% | 2 |
9 | PROTEASES CANC PROGRAM | 34824 | 0% | 33% | 5 |
10 | AG PROT DYNAM | 27864 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 31214 | 13% | 1% | 194 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 10644 | 7% | 0% | 105 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY | 6720 | 4% | 1% | 65 |
4 | EXPERT OPINION ON THERAPEUTIC PATENTS | 5832 | 2% | 1% | 25 |
5 | CHEMMEDCHEM | 2925 | 1% | 1% | 18 |
6 | CHEMICAL BIOLOGY & DRUG DESIGN | 2116 | 1% | 1% | 13 |
7 | MATRIX BIOLOGY | 1863 | 1% | 1% | 11 |
8 | JOURNAL OF ENZYME INHIBITION | 1458 | 0% | 1% | 5 |
9 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 1281 | 1% | 1% | 11 |
10 | ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA | 1248 | 0% | 2% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TACE INHIBITORS | 752899 | 3% | 97% | 37 | Search TACE+INHIBITORS | Search TACE+INHIBITORS |
2 | MMP INHIBITORS | 329951 | 3% | 34% | 46 | Search MMP+INHIBITORS | Search MMP+INHIBITORS |
3 | MATRIX METALLOPROTEINASE INHIBITOR | 268257 | 3% | 26% | 49 | Search MATRIX+METALLOPROTEINASE+INHIBITOR | Search MATRIX+METALLOPROTEINASE+INHIBITOR |
4 | GELATINASE INHIBITOR | 194515 | 1% | 85% | 11 | Search GELATINASE+INHIBITOR | Search GELATINASE+INHIBITOR |
5 | ZINC BINDING GROUP | 147290 | 1% | 41% | 17 | Search ZINC+BINDING+GROUP | Search ZINC+BINDING+GROUP |
6 | MMP 2 INHIBITORS | 146290 | 0% | 100% | 7 | Search MMP+2+INHIBITORS | Search MMP+2+INHIBITORS |
7 | HYDROXAMATE | 128235 | 3% | 17% | 37 | Search HYDROXAMATE | Search HYDROXAMATE |
8 | MATRIX METALLOPROTEINASE | 107131 | 13% | 3% | 193 | Search MATRIX+METALLOPROTEINASE | Search MATRIX+METALLOPROTEINASE |
9 | MMP SELECTIVITY | 83595 | 0% | 100% | 4 | Search MMP+SELECTIVITY | Search MMP+SELECTIVITY |
10 | CGS 27023A | 62696 | 0% | 100% | 3 | Search CGS+27023A | Search CGS+27023A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAO, BG , (2005) RECENT DEVELOPMENTS IN THE DESIGN OF SPECIFIC MATRIX METALLOPROTEINASE INHIBITORS AIDED BY STRUCTURAL AND COMPUTATIONAL STUDIES.CURRENT PHARMACEUTICAL DESIGN. VOL. 11. ISSUE 3. P. 295-322 | 113 | 87% | 147 |
2 | AURELI, L , GIOIA, M , CERBARA, I , MONACO, S , FASCIGLIONE, GF , MARINI, S , ASCENZI, P , TOPAI, A , COLETTA, M , (2008) STRUCTURAL BASES FOR SUBSTRATE AND INHIBITOR RECOGNITION BY MATRIX METALLOPROTEINASES.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 22. P. 2192-2222 | 134 | 68% | 44 |
3 | JACOBSEN, JA , JOURDEN, JLM , MILLER, MT , COHEN, SM , (2010) TO BIND ZINC OR NOT TO BIND ZINC: AN EXAMINATION OF INNOVATIVE APPROACHES TO IMPROVED METALLOPROTEINASE INHIBITION.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1803. ISSUE 1. P. 72-94 | 100 | 72% | 72 |
4 | WHITTAKER, M , FLOYD, CD , BROWN, P , GEARING, AJH , (1999) DESIGN AND THERAPEUTIC APPLICATION OF MATRIX METALLOPROTEINASE INHIBITORS.CHEMICAL REVIEWS. VOL. 99. ISSUE 9. P. 2735 -2776 | 132 | 46% | 707 |
5 | SERRA, P , BRUCZKO, M , ZAPICO, JM , PUCKOWSKA, A , GARCIA, MA , MARTIN-SANTAMARIA, S , RAMOS, A , DE PASCUAL-TERESA, B , (2012) MMP-2 SELECTIVITY IN HYDROXAMATE-TYPE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 7. P. 1036-1064 | 91 | 71% | 16 |
6 | SKILES, JW , GONNELLA, NC , JENG, AY , (2004) THE DESIGN, STRUCTURE, AND CLINICAL UPDATE OF SMALL MOLECULAR WEIGHT MATRIX METALLOPROTEINASE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 22. P. 2911-2977 | 105 | 66% | 134 |
7 | LI, NG , SHI, ZH , TANG, YP , WANG, ZJ , SONG, SL , QIAN, LH , QIAN, DW , DUAN, JA , (2011) NEW HOPE FOR THE TREATMENT OF OSTEOARTHRITIS THROUGH SELECTIVE INHIBITION OF MMP-13.CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 7. P. 977 -1001 | 89 | 67% | 35 |
8 | FABRE, B , RAMOS, A , DE PASCUAL-TERESA, B , (2014) TARGETING MATRIX METALLOPROTEINASES: EXPLORING THE DYNAMICS OF THE S1' POCKET IN THE DESIGN OF SELECTIVE, SMALL MOLECULE INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 24. P. 10205 -10219 | 79 | 72% | 5 |
9 | LI, BK , CONG, Y , TIAN, ZY , XUE, Y , (2014) PREDICTING AND VIRTUALLY SCREENING THE SELECTIVE INHIBITORS OF MMP-13 OVER MMP-1 BY MOLECULAR DESCRIPTORS AND MACHINE LEARNING METHODS.ACTA PHYSICO-CHIMICA SINICA. VOL. 30. ISSUE 1. P. 171-+ | 71 | 71% | 1 |
10 | LI, NG , SHI, ZH , TANG, YP , WEI-LI , LIAN-YIN , DUAN, JA , (2012) DISCOVERY OF SELECTIVE SMALL MOLECULAR TACE INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 18. P. 2924-2956 | 81 | 62% | 9 |
Classes with closest relation at Level 1 |